Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 6-India, big vaccine exporter, now seeks imports as COVID-19 cases soar

Tue, 13th Apr 2021 08:54

* India reports 161,736 new infections, total at 13.7 mln

* Deaths rise by 879

* India has administered more than 106 mln vaccine doses
(Adds details on India's richest state imposing restrictions)

By Alasdair Pal and Krishna N. Das

NEW DELHI, April 13 (Reuters) - India on Tuesday said it
will fast-track emergency approvals for COVID-19 vaccines
authorised by Western countries and Japan, paving the way for
possible imports of Pfizer, Johnson & Johnson,
and Moderna shots.

The move, which will exempt companies from carrying out
local safety trials for their vaccines, follows the world's
biggest surge in cases in the country this month.

Since April 2, India has reported the highest daily tallies
of infections. It reported 161,736 cases on Tuesday, taking the
total to 13.7 million, while deaths rose by 879 to 171,058.

On Tuesday, India's richest state Maharashtra, which
accounts for about a quarter of the country's cases, said it
would impose stringent restrictions from Wednesday to try to
contain the spread.

India has the biggest global vaccine manufacturing capacity
and had exported tens of millions of doses before its own demand
skyrocketed and led to a shortage in some states.

Dozens of poor countries have relied on Indian exports to
run their inoculation drives.

The health ministry said vaccines authorised by the World
Health Organization or authorities in the United States, Europe,
Britain and Japan could be granted emergency use approval in
India.

"If any of these regulators have approved a vaccine, the
vaccine is now ready to be brought into the country for use,
manufacture and fill-and-finish," Vinod Kumar Paul, a senior
government health official, told a news conference.

"We hope and we invite the vaccine makers such as Pfizer,
Moderna, Johnson & Johnson and others ... to be ready to come to
India as early as possible."

Pfizer said it would work towards bringing its vaccine to
India after withdrawing its application in February.

U.S. federal health agencies on Tuesday recommended pausing
use of the J&J shot after six women under age 50 developed rare
blood clots after receiving it.

India has administered more than 108 million vaccine doses,
sold more than 54.6 million vaccine doses abroad and gifted more
than 10 million to partner countries.

It is currently using the AstraZeneca shot and a
homegrown vaccine for its own immunisation drive, and this week
approved Russia's Sputnik V shot for emergency use.

RALLIES, RELIGIOUS GATHERINGS

The jump in India's infections, for which Health Minister
Harsh Vardhan acknowledged https://www.reuters.com/article/us-health-coronavirus-india-surge-idUSKBN2BV129
widespread failure to heed curbs on movement and social
interaction, has prompted calls for the government to cancel
huge public events.

Still, hundreds of thousands of devout Hindus are set to
bathe in the Ganges river on Wednesday, the third key day of the
weeks-long Kumbh Mela - or pitcher festival.

Nearly a million bathed in the Ganges on Monday in the
belief that its waters would wash away their sins. More than 100
tested positive for COVID-19 in random testing of around 18,000
attendees, media said.

Similar concerns of a spike in cases were sparked by mass
election rallies by Prime Minister Narendra Modi's party and
opposition groups during polls in four states and one federally
run region.

At one rally in the eastern state of West Bengal, a key
political prize, Home Minister Amit Shah posted Twitter pictures
of meetings with crowds of supporters while unmasked.

DEADLY SPREAD

The second wave of infections, which began in India's major
cities, is increasingly spreading into the hinterland, where
healthcare facilities are often rudimentary.

In Raipur, the capital of Chhattisgarh state known for its
large tribal population, the main government hospital's morgue
was struggling to keep up, said joint director Dr Vineet Jain.

"All oxygenated and ICU beds are full in our set-up," he
told Reuters.

"Around 50 dead bodies are laying, we have a shortage of
space. Some private hospitals do not have space to keep the dead
bodies so they also send the bodies to us."

India is currently reporting around double the daily cases
of the United States and Brazil, the two other worst affected
countries, though its daily death toll is lower.

India's total infections rank after only the United States,
having overtaken Brazil on Monday.

(Global vaccination tracker: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/)

(Interactive graphic tracking global spread of coronavirus:
https://graphics.reuters.com/world-coronavirus-tracker-and-maps/)

(Reporting by Krishna N. Das and Alasdair Pal in New Delhi and
Jatindra Dash in Bhubaneswar; Editing by Nick Macfie, Ana
Nicolaci da Costa and John Stonestreet)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.